Inhibition of thymidylate kinase and DNA polymerase by the periodate oxidation product of beta-D-ribosyl-6-methylthiopurine.

A. Kimball,M. Wilson,J. Bell,G. Lepage
IF: 11.2
1968-04-01
Cancer Research
Abstract:It was demonstrated that the periodate oxidation product of β-d-ribosyl-6-methylthiopurine (Me6MPR-OP) increased the survival times of mice bearing the Ehrlich ascites tumor. Me6MPR-OP at 75 mg/kg inhibited the incorporation of thymidine-3H into DNA thymine of the Ehrlich ascites tumor by 90–95%. Enzyme studies showed that Me6MPR-OP inhibited thymidine-5′-monophosphate kinase (TMP kinase) and DNA polymerase to produce a sequential blockade in the incorporation of TMP into DNA. At molarities of Me6MPR-OP that were inhibitory, the β-d-ribosyl-6-methylthiopurine did not inhibit the thymidine or TMP kinases, or significantly inhibit DNA polymerase.
What problem does this paper attempt to address?